Skip to main content
. 2017 Oct 4;8(52):90197–90214. doi: 10.18632/oncotarget.21644

Figure 5. Forest plots of sensitivity and specifcity for circulating miRNAs in the diagnosis of stage I/II lung cancer.

Figure 5